MEDNAX (MD) Misses Q4 EPS by 6c; Guides Q1 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00
February 7, 2017 6:00 AM ESTFORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, maternal-fetal medicine, other pediatric services, radiology, and management services, today reported earnings of $0.84 per diluted share for the three months ended December 31, 2016. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $1.00.
For the 2016 fourth quarter, MEDNAX reported:
Revenue growth of 12.0 percent to $831 million; Net income of $78 million; EBITDA of $168 million; and EPS of $0.84 and Adjusted EPS of $1.00.... More